Lupus Treatment Advances: Agents in the Pipeline

Novel therapies in the pipeline that demonstrate potential advantages when used as treatment for systemic lupus erythematosus and lupus nephritis.

Related Content:

Rheumatology

Obesity, Nail Psoriasis May Increase Psoriatic Arthritis Risk in Children with Psoriasis

Study Highlights Neuroscience Education, Resistance Training in Women With Fibromyalgia

Phase 4 Studies Support Alternative Pegloticase Dosing Regimens for Uncontrolled Gout, with Orrin Troum, MD